| European Case Law Identifier: | ECLI:EP:BA:2002:T089000.20021028 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 28 October 2002 | ||||||||
| Case number: | T 0890/00 | ||||||||
| Application number: | 94920360.8 | ||||||||
| IPC class: | A61K 9/16 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Anti-angiogenic compositions and methods of use | ||||||||
| Applicant name: | Angiotech Pharmaceuticals, Inc., et al | ||||||||
| Opponent name: | (I) Schering AG (II) Focal, Inc. (III) Inflow Dynamics AG (IV) STS Biopolymers Inc. (V) Abbott Vascular Devices Limited |
||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Remittal to the first instance for further prosecution- New main request not examined for all EPC requirements Apportionment of costs (no): more appropriate for decision at end of further first instance proceedings |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t000890eu1.html
Date retrieved: 17 May 2021
